telbivudine has been researched along with Bright Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gou, W; Qiao, B; Wang, Y; Yan, Z; Zhang, H | 1 |
1 other study(ies) available for telbivudine and Bright Disease
| Article | Year |
|---|---|
Effectiveness of telbivudine antiviral treatment in patients with hepatitis B virus-associated glomerulonephritis: A 104-week pilot study.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; DNA, Viral; Female; Glomerular Filtration Rate; Glomerulonephritis; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Male; Middle Aged; Pilot Projects; Proteinuria; Remission Induction; Telbivudine; Thymidine; Viral Load; Young Adult | 2018 |